Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enteric, buffered and regular aspirin produce equal risk of GI bleeding -- Lancet study.

This article was originally published in The Tan Sheet

Executive Summary

ENTERIC-COATED, BUFFERED, REGULAR ASPIRIN PRODUCE NEARLY EQUAL UPPER GI BLEEDING rates, researcher Judith Kelly, Boston University School of Medicine, et al., reported in a Nov. 23 Lancet article. "Our results suggest that, dose for dose, there is no substantial difference in the risk of major UGIB (upper gastrointestinal bleeding) according to the type of aspirin preparation that is used," the authors concluded.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086389

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel